ED-TBI Followed By Allogeneic Stem Cell Transplantation For The Treatment Of Refractory AML And Advanced MDS

NCT01709396 · clinicaltrials.gov ↗
PHASE2
Phase
SUSPENDED
Status
20
Enrollment
OTHER
Sponsor class

Stopped initial on hold due to space but now permanently suspended due to futility.

Conditions

Interventions

Sponsor

Ottawa Hospital Research Institute